Serological methods can be rapid, sensitive, and specific and therefore are important tools in diagnostic laboratories. However, the major limitation of conventional antisera is standardization. Most antisera are heterogeneous mixtures of antibodies differing in specificity and affinity for the antigenic determinants. Furthermore, it is probably true that no two animals produce antisera that are precisely alike. Absorption to remove unwanted specificities is another source of variability. For these reasons, comparison of results between laboratories using different reagents is difficult. The recent developments in hybridoma technology overcome these limitations by providing immortal cell fines that produce monoclonal antibody. We report in this study the clinical evaluation of a hybridoma antibody prepared against group A streptococcal carbohydrate.
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MATERIALS AND METHODS Hybridoma production. Spleen cells from an A/ J mouse hyperimmunized with group A streptococcal vaccine (1) were fused to the mouse plasmacytoma cell line NSI/1-Ag 4-1 by using essentially the procedure of Galfre et al. (6) . Approximately 108 splenocytes were fused with polyethylene glycol (Carbowax PEG 1500; Fisher Scientific Co., Fair Lawn, N.J.) to 10' myeloma cells. After 2 weeks of growth in selection medium (8) , culture supernatants were analyzed for anti-group A carbohydrate (GAC) activity by '25I-GAC binding after isoelectric focusing in acrylamide gels (10) . Cells demonstrating anti-GAC activity were cloned in soft agar over 3T3 mouse fibroblast monolayers (4) . About 107 cells from the positive clones were injected intraperitoneally into pristane-treated BALB/c mice. Within 10 to 20 days the ascites fluid contained about 5 mg of hybridoma protein per ml. The hybridoma used in this study, HGAC-1, produces an immunoglobulin G3 (K) protein, which was purified from ascitic fluid by 50%o ammonium sulfate precipitation followed by euglobulin precipitation. The purified protein produced a single band by microzone electrophoresis.
Bacteria. The organisms used in these studies were recovered initially from clinical specimens and included 38 bacitracin-sensitive, beta-hemolytic streptococci from St. Louis Children's Hospital (provided by Thomas Brotherton) and 224 randomly selected beta-hemolytic streptococci from Barnes Hospital.
Lancefield precipitin test. The Rantz-Randall autoclave extraction method (11) was used to prepare the carbohydrate extract. Several isolated colonies of beta-hemolytic streptococci were inoculated into 12 ml of Todd-Hewitt broth. After overnight incubation, the beta-hemolytic streptococci were concentrated by centrifugation, suspended in 0.8 ml of sterile saline, and autoclaved for 15 min at 121°C. The samples were centrifuged for 10 min at 1,500 x g, and the supernatant fluids were analyzed for group-specific streptococcal carbohydrates. The precipitin test (7) (2) .
There were several reasons for using an anti-GAC hybridoma antibody to demonstrate the clinical usefulness of a monoclonal antibody. First and most importantly, the accurate typing of streptococci is an important and frequently used clinical test. Second, the Lancefield precipitin test could provide definitive serological results with which to compare the results of HGAC-1. Third, the antigenic determinant of the GAC is well defined and known to involve the terminal N-acetylglucosamine on a rhamnose core (5) . HGAC-1 binds to N-acetylglucosamine conjugated to bovine serum albumin, substantiating its specificity for the N-acetylglucosamine hapten (unpublished data).
We have demonstrated here that a monoclonal reagent can be superior to conventional antisera in bacterial typing. Clearly, if this hybridoma is used in other clinical laboratories, results from these laboratories should be directly comparable. Furthermore, highly accurate and plentiful reagents should facilitate the development of other tests for earlier detection. In the past, throat swabs have been analyzed directly by immunofluorescence (9) . Direct analysis of throat swabs, using enzyme-linked immunosorbent assays or immunofluorescence assays, are also feasible with these improved reagents. It is 
